Drugs / CS-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07166354 | Oct 2025 → Jun 2027 expected | — | Applied Biology, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CS-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07166354 ↗ |
| Action | Inhibit | “CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)” NCT07166354 ↗ |
| Modality | Small molecule | “CS-002 is a small molecule” NCT07166354 ↗ |
| Route | Topical | “CS-002 Topical Treatment” NCT07166354 ↗ |